Clinical Trial Update: Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating PCSK9 inhibition in patients with acute ischemic stroke and symptomatic intracranial atherosclerosis, with the study currently lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Atherosclerosis
• Stroke

Drugs mentioned

• PCSK9 inhibitor (PCSK9 inhibitor)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Intracranial Atherosclerosis, Acute Ischemic Stroke | Phase 2 | Status: ACTIVE_NOT_RECRUITING